Results 131 to 140 of about 935,725 (295)

Interrogating the immune landscape of microsatellite stable RAS‐mutated colon cancer

open access: yesMolecular Oncology, EarlyView.
COLOSSUS project RAS‐mutated MSS colon cancer study explored transcriptomics and immune cell density by immunohistochemistry (IHC), Immunoscore (IS), ISIC/TuLIS scores, mutation counts, and detected different prevalences but similar microenvironment composition across immune markers with clinical relevance for future immunotherapy combination ...
Rodrigo Dienstmann   +61 more
wiley   +1 more source

CLINICAL DECISION SUPPORT FOR IMMUNIZATION (CDSI): LOGIC SPECIFICATION FOR ACIP RECOMMENDATIONS. Version 4.5 [PDF]

open access: yes
In 2022, approximately 98% of U.S. children under the age of six participated1 in an Immunization Information System (IIS), an increase from 82% in 2010. 2 Adolescent participation in 2022 was 82%, up from 60% in 2010.

core  

Decision discovery using clinical decision support system decision log data for supporting the nurse decision-making process

open access: yesBMC Medical Informatics and Decision Making
Background Decision-making in healthcare is increasingly complex; notably in hospital environments where the information density is high, e.g., emergency departments, oncology departments, and psychiatry departments. This study aims to discover decisions
Matthijs Berkhout   +2 more
doaj   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

open access: yesMolecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla   +9 more
wiley   +1 more source

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Keratin 19 (KRT19) is overexpressed in high‐grade serous ovarian cancer with high levels of Kallikrein‐related peptidases (KLK) 4–7 and is associated with poor survival. In vivo analyses demonstrate that elevated KRT19 increases peritoneal tumour burden.
Sophia Bielesch   +13 more
wiley   +1 more source

Capture and Reuse of Knowledge in ICT-based Decisional Environments [PDF]

open access: yes
Health care practitioners continually confront with a wide range of challenges, seeking to making difficult diagnoses, avoiding errors, ensuring highest quality, maximizing efficacy and reducing costs.
Florin Gheorghe FILIP   +1 more
core  

Knowledge management system for clinical decision support Application in cardiology

open access: yes, 2011
Clinical decision support systems have been recognized as promising tools for influencing healthcare provider performance to improve and streamline the quality of healthcare delivery. In this paper we present the knowledge management module, developed as
Jelica Grujic Milanovic   +13 more
core   +1 more source

Somatic mutational landscape in von Hippel–Lindau familial hemangioblastoma

open access: yesMolecular Oncology, EarlyView.
The causes of central nervous system (CNS) hemangioblastoma in Von Hippel–Lindau (vHL) disease are unclear. We used Whole Exome Sequencing (WES) on familial hemangioblastoma to investigate events that underlie tumor development. Our findings suggest that VHL loss creates a permissive environment for tumor formation, while additional alterations ...
Maja Dembic   +5 more
wiley   +1 more source

Dual PI3K/AKT and CDK4/6 inhibition reveals selective sensitivity in an SHH medulloblastoma stem cell model

open access: yesMolecular Oncology, EarlyView.
Targeted therapy was evaluated in SHH medulloblastoma using neuroepithelial stem cell (NES) and tumor‐derived NES‐like (tNES) models in 2D monolayers and 3D spheroids. PI3K, AKT, and CDK4/6 inhibitors had minimal effects in NES but markedly reduced viability and growth and induced apoptosis in tNES cells, revealing distinct therapeutic vulnerabilities.
Monika Lukoseviciute   +4 more
wiley   +1 more source

Challenges of Clinical Decision Support System Development

open access: yes, 2016
One of the high-growing areas in medicine is research and development of advanced IT technologies for clinical decision support. Clinical decision support system (CDSS) must be able to store the necessary clinical data and also to analyze this data, and ...
Fetter, Miloš   +6 more
core  

Home - About - Disclaimer - Privacy